
Soleno Therapeutics SLNO
€ 40.37
-0.31%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Soleno Therapeutics EV 2011-2025 | SLNO
EV Jährlich Soleno Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.95 B | 657 M | 18.9 M | -1.66 M | 126 M | 112 M | 25.7 M | 11 M | 12.5 M | 12.1 M | 12.5 M | 38.2 M | 36.7 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.95 B | -1.66 M | 232 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 19.0 | -1.91 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 20.35 | -3.9 % | $ 219 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.23 | -3.36 % | $ 6.75 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 39.13 | -0.69 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
150 B | $ 231.04 | 0.3 % | $ 169 B | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 10.36 | 3.19 % | $ 294 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.51 | -0.99 % | $ 1.92 M | ||
|
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.8 | 0.23 % | $ 18.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
DexCom
DXCM
|
52.4 B | $ 67.74 | 0.24 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 26.57 | -0.56 % | $ 803 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 19.14 | -1.77 % | $ 1.03 B | ||
|
Celcuity
CELC
|
506 M | $ 100.96 | -1.26 % | $ 3.98 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
1.5 M | $ 3.19 | -0.31 % | $ 102 K | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 227.39 | 0.21 % | $ 41.2 B | ||
|
Guardant Health
GH
|
6.94 B | $ 101.27 | -1.67 % | $ 12.4 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 7.19 | 0.84 % | $ 1.56 B | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
1.2 B | $ 6.36 | -1.93 % | $ 576 M | ||
|
National Research Corporation
NRC
|
1.08 B | $ 19.02 | 1.93 % | $ 467 M | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 4.67 | -8.07 % | $ 2.51 M | ||
|
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 27.25 | 0.53 % | $ 20 B | ||
|
Personalis
PSNL
|
229 M | $ 8.03 | -1.35 % | $ 476 M | ||
|
Illumina
ILMN
|
15.3 B | $ 134.32 | -0.47 % | $ 21.4 B | ||
|
RadNet
RDNT
|
5.09 B | $ 72.95 | -0.27 % | $ 5.33 B | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 202.73 | -0.41 % | $ 10.4 B | ||
|
Quidel Corporation
QDEL
|
460 M | $ 29.16 | -0.48 % | $ 1.23 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 175.35 | -0.34 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
142 M | $ 6.79 | -0.44 % | $ 880 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 252.96 | -0.37 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 182.54 | -0.16 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
39.1 B | $ 684.86 | -0.53 % | $ 56.5 B | ||
|
Lantheus Holdings
LNTH
|
6.44 B | $ 66.89 | 0.27 % | $ 4.63 B | ||
|
Mettler-Toledo International
MTD
|
33.2 B | $ 1 417.22 | -0.2 % | $ 30.1 B |